Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

"Akinetic depression" in schizophrenia.

Van Putten T, May RP.

Arch Gen Psychiatry. 1978 Sep;35(9):1101-7.

PMID:
28711
2.
3.

Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate.

Hogarty GE, Munetz MR.

J Clin Psychopharmacol. 1984 Feb;4(1):17-24.

PMID:
6141187
4.

[Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].

Langlois-Thery S, Dollfus S, Lesieur P, Petit M.

Encephale. 1994 Sep-Oct;20(5):487-93. French.

PMID:
7828511
5.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

6.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
7.
8.

The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.

Brar JS, Chengappa KN, Parepally H, Sandman AR, Kreinbrook SB, Sheth SA, Ganguli R.

Ann Clin Psychiatry. 1997 Dec;9(4):227-34. Review.

PMID:
9511946
9.

New drugs for schizophrenia: an update for family physicians.

Amadio PB, Cross LB, Amadio P Jr.

Am Fam Physician. 1997 Sep 15;56(4):1149-56, 1159-60. Review. Erratum in: Am Fam Physician 1998 Jan 1;57(1):40.

PMID:
9310066
10.

Déjà vu experiences in schizophrenia: relations with psychopathology and antipsychotic medication.

Adachi N, Adachi T, Akanuma N, Matsubara R, Ito M, Takekawa Y, Ikeda H, Arai H.

Compr Psychiatry. 2007 Nov-Dec;48(6):592-6.

PMID:
17954146
11.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
12.

Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia.

Chemerinski E, Ho BC, Flaum M, Arndt S, Fleming F, Andreasen NC.

Compr Psychiatry. 2002 Sep-Oct;43(5):393-6.

PMID:
12216015
13.

Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study.

Marco EJ, Wolkowitz OM, Vinogradov S, Poole JH, Lichtmacher J, Reus VI.

World J Biol Psychiatry. 2002 Jul;3(3):156-61.

PMID:
12478881
14.

Sleep polygraphy in schizophrenia: methodological issues.

Thaker GK, Wagman AM, Tamminga CA.

Biol Psychiatry. 1990 Aug 1;28(3):240-6.

PMID:
1974153
15.

Is neuroleptic dysphoria a healthy response?

Weiden PJ, Mann JJ, Dixon L, Haas G, DeChillo N, Frances AJ.

Compr Psychiatry. 1989 Nov-Dec;30(6):546-52.

PMID:
2573481
16.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

17.

[Incidence of the deficit form in refractory schizophrenia].

Samuelian JC.

Encephale. 1996 Jun;22 Spec No 2:19-23. Review. French.

PMID:
8767037
18.

Akinesia and postpsychotic depression: a difficult differential diagnosis.

Siris SG.

J Clin Psychiatry. 1987 Jun;48(6):240-3.

PMID:
2884213
19.

Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.

Bandelow B, Müller P, Gaebel W, Köpcke W, Linden M, Müller-Spahn F, Pietzcker A, Reischies FM, Tegeler J.

Eur Arch Psychiatry Clin Neurosci. 1990;240(2):113-20.

PMID:
1981149
20.

Aspects of dysphoria and symptoms of schizophrenia.

Norman RM, Malla AK, Cortese L, Diaz F.

Psychol Med. 1998 Nov;28(6):1433-41.

PMID:
9854284

Supplemental Content

Support Center